Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
293
-
Total 13F shares, excl. options
-
42.9M
-
Shares change
-
+1.77M
-
Total reported value, excl. options
-
$4.07B
-
Value change
-
+$175M
-
Put/Call ratio
-
0.58
-
Number of buys
-
137
-
Number of sells
-
-160
-
Price
-
$94.83
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2020
379 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2020.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.9M shares
of 44.8M outstanding shares and own 95.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.46M shares), VANGUARD GROUP INC (4.14M shares), RENAISSANCE TECHNOLOGIES LLC (3.59M shares), FMR LLC (2.51M shares), STATE STREET CORP (1.92M shares), CITADEL ADVISORS LLC (1.4M shares), Consonance Capital Management LP (1.35M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.29M shares), DIMENSIONAL FUND ADVISORS LP (899K shares), and Palo Alto Investors LP (877K shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.